Doctor Admits of Leaking Safety Information to GSK
February 1st, 2008 • Related • Filed Under
WASHINGTON, Jan. 30 — Citing a bad case of poor judgment, an independent reviewer for the New England Journal of Medicine has conceded that he leaked privileged information to GlaxoSmithKline last May on a meta-analysis that cast the company’s diabetes drug rosiglitazone (Avandia) in a bad light.
Popularity: 36% [?]
